Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...

Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on ...

Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...

Drug distributor Cencora (NYSE:COR) agreed to repurchase shares of its common stock from Walgreens Boots Alliance (NASDAQ:WBA) for ~$50M in concurrence with Walgreens Boots Alliance’s sale of Cencora ...

Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and ...

Feb 6 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance (WBA.O), opens new tab said on Thursday it has sold more shares in drug distributor Cencora (COR.N), opens new tab for proceeds of ...